• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自1996年以来,荷兰用于细胞学报告的CISOE - A框架通过标准化提高了筛查效率。

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.

作者信息

Bulk S, Van Kemenade F J, Rozendaal L, Meijer C J L M

机构信息

Department of Pathology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands.

出版信息

J Clin Pathol. 2004 Apr;57(4):388-93. doi: 10.1136/jcp.2003.011841.

DOI:10.1136/jcp.2003.011841
PMID:15047743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1770272/
Abstract

AIM

To describe the effect of introducing the CISOE-A framework for reporting cervical cytology results, including changes in repeat and referral advice in the Netherlands, on the efficacy of the screening programme. Changes in the distribution of cytological results, the detection rate of cervical intraepithelial neoplasia (CIN) lesions, and the detection rate of squamous cervical carcinoma are reported.

METHODS

The results of all gynaecology cytological and histological examinations, as registered in the nationwide database for histopathology and cytopathology (PALGA) from 1990 to 2000, were retrieved from seven laboratories in the greater Amsterdam area.

RESULTS

After the introduction of the CISOE-A classification, cytological results with equivocal diagnoses decreased significantly from 11.3% to 2.6%, without an increase in the percentages of moderate dyskaryosis or worse. During the study period, the detection rate of histologically diagnosed high grade CIN lesions increased significantly from 4.1 to 6.4/1000 smears, whereas there was no change in the detection rates of low grade lesions or invasive cervical cancer.

CONCLUSIONS

The introduction of the new CISOE-A classification system resulted in a substantial decrease of equivocal results and repeat recommendations, without a decrease in the detection rate of high grade lesions, making the screening programme more efficacious.

摘要

目的

描述引入用于报告宫颈细胞学检查结果的CISOE-A框架(包括荷兰重复检查和转诊建议的变化)对筛查计划效果的影响。报告细胞学检查结果的分布变化、宫颈上皮内瘤变(CIN)病变的检出率以及宫颈鳞癌的检出率。

方法

从1990年至2000年在全国组织病理学和细胞病理学数据库(PALGA)中登记的所有妇科细胞学和组织学检查结果,取自阿姆斯特丹大区的七个实验室。

结果

引入CISOE-A分类后,诊断不明确的细胞学检查结果从11.3%显著降至2.6%,中度核异质或更严重情况的百分比没有增加。在研究期间,组织学诊断的高级别CIN病变的检出率从4.1/1000涂片显著增加至6.4/1000涂片,而低级别病变或浸润性宫颈癌的检出率没有变化。

结论

新的CISOE-A分类系统的引入导致不明确结果和重复建议大幅减少,而高级别病变的检出率没有降低,使筛查计划更有效。

相似文献

1
The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.自1996年以来,荷兰用于细胞学报告的CISOE - A框架通过标准化提高了筛查效率。
J Clin Pathol. 2004 Apr;57(4):388-93. doi: 10.1136/jcp.2003.011841.
2
Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.荷兰基于细胞学与基于高危型人乳头瘤病毒的宫颈癌筛查项目中的获益与负担
Am J Obstet Gynecol. 2021 Feb;224(2):200.e1-200.e9. doi: 10.1016/j.ajog.2020.08.026. Epub 2020 Aug 13.
3
Baseline human papillomavirus status of women with abnormal smears in cervical screening: a 5-year follow-up study in The Netherlands.宫颈筛查中涂片异常女性的人乳头瘤病毒基线状态:荷兰一项为期5年的随访研究
BJOG. 2007 Aug;114(8):951-7. doi: 10.1111/j.1471-0528.2007.01390.x. Epub 2007 Jun 18.
4
Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.在未进行人乳头瘤病毒(HPV)检测的情况下,对于轻度宫颈细胞学异常,立即转诊至阴道镜检查与细胞学监测的比较
Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD009836. doi: 10.1002/14651858.CD009836.pub2.
5
Referral compliance, outcome and predictors of CIN after repeated borderline cervical smears in the Netherlands.荷兰重复出现宫颈涂片结果为临界异常后的转诊依从性、结局及宫颈上皮内瘤变的预测因素
Cytopathology. 2007 Apr;18(2):96-104. doi: 10.1111/j.1365-2303.2007.00427.x.
6
High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.对患有交界性和轻度核异质的女性进行高危型人乳头瘤病毒检测:长期随访数据及临床意义
J Pathol. 2001 Oct;195(3):300-6. doi: 10.1002/path.981.
7
Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more.高危型人乳头瘤病毒(HPV)阳性女性的低级别涂片中有挖空细胞,是宫颈上皮内瘤变3级或更高级别的阴性预测指标。
Cytopathology. 2018 Jun;29(3):275-280. doi: 10.1111/cyt.12536. Epub 2018 Mar 25.
8
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.人乳头瘤病毒检测在高级别宫颈上皮内瘤变和宫颈癌筛查中的应用:POBASCAM 随机对照研究的最终结果。
Lancet Oncol. 2012 Jan;13(1):78-88. doi: 10.1016/S1470-2045(11)70296-0. Epub 2011 Dec 14.
9
Cytology versus HPV testing for cervical cancer screening in the general population.普通人群宫颈癌筛查中细胞学检查与HPV检测的比较
Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2.
10
The development of the referral outcome diagram and an analysis of laboratory cancer detection rates in the English NHS cervical screening programme--is there an optimum level of detection of CIN 1 and CIN 2 lesions?英国国民医疗服务体系(NHS)宫颈筛查项目中转诊结果图的绘制及实验室癌症检出率分析——CIN 1和CIN 2病变的最佳检出水平是否存在?
Cytopathology. 2008 Aug;19(4):244-53. doi: 10.1111/j.1365-2303.2008.00558.x. Epub 2008 May 9.

引用本文的文献

1
The Risk of Developing Cervical Cancer in the Elderly: Who Benefits From Screening After the Age of 60?老年人患宫颈癌的风险:60岁以后哪些人能从筛查中获益?
J Low Genit Tract Dis. 2025 Jul 1;29(3):229-234. doi: 10.1097/LGT.0000000000000893. Epub 2025 Apr 18.
2
Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.评价基于 HPV 初筛的 HPV 阳性自我采样标本中 DNA 甲基化生物标志物 ASCL1 和 LHX8 的应用。
Br J Cancer. 2023 Jul;129(1):104-111. doi: 10.1038/s41416-023-02277-z. Epub 2023 Apr 26.
3
Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands.荷兰年轻女性中双价人乳头瘤病毒疫苗接种对宫颈样本细胞学结果的早期影响。
Cancer Med. 2023 May;12(10):11786-11794. doi: 10.1002/cam4.5842. Epub 2023 Mar 25.
4
Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of DNA Methylation (CONCERVE Study).高级别宫颈上皮内瘤变的临床消退与 DNA 甲基化缺失相关(CONCERVE 研究)。
J Clin Oncol. 2022 Sep 10;40(26):3037-3046. doi: 10.1200/JCO.21.02433. Epub 2022 May 5.
5
Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study.荷兰常规初级HPV筛查中高危型HPV自我采样与临床医生采样的临床性能:一项观察性研究。
Lancet Reg Health Eur. 2021 Nov 9;11:100235. doi: 10.1016/j.lanepe.2021.100235. eCollection 2021 Dec.
6
Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping.基于 FAM19A4/miR124-2 甲基化和 HPV 基因分型对低级别细胞学 HPV 阳性女性进行风险分层。
Br J Cancer. 2022 Feb;126(2):259-264. doi: 10.1038/s41416-021-01614-4. Epub 2021 Nov 6.
7
Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort.ASCL1、LHX8、ST6GALNAC5、GHSR、ZIC1 和 SST 的 DNA 甲基化分析在 HPV 阳性女性分流中的表现:来自荷兰基于 HPV 的初级筛查队列的结果。
Int J Cancer. 2022 Feb 1;150(3):440-449. doi: 10.1002/ijc.33820. Epub 2021 Oct 13.
8
Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.HPV 自我采样作为一种替代方法在筛查不足人群中进行宫颈癌初筛的可接受性和可行性:一项横断面研究。
Int J Environ Res Public Health. 2020 Aug 27;17(17):6245. doi: 10.3390/ijerph17176245.
9
Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer.估算人乳头瘤病毒疫苗接种对筛查发现的宫颈癌前病变终生风险的直接影响。
Int J Cancer. 2021 Jan 15;148(2):320-328. doi: 10.1002/ijc.33207. Epub 2020 Jul 28.
10
Reflex cytology for triage of high-risk human papillomavirus positive self-sampled material in cervical cancer screening: a prospective cohort study.用于宫颈癌筛查中高危型人乳头瘤病毒阳性自我采样标本分流的细胞学反射检查:一项前瞻性队列研究。
BJOG. 2020 Dec;127(13):1656-1663. doi: 10.1111/1471-0528.16352. Epub 2020 Jul 3.

本文引用的文献

1
Screening for cervical disease in mature women: strategies for improvement.成年女性宫颈疾病筛查:改进策略
Cancer. 2002 Aug 25;96(4):195-203. doi: 10.1002/cncr.10723.
2
Criteria for organized cervical screening programs. Special emphasis on The Netherlands program.有组织的宫颈筛查计划标准。特别强调荷兰的计划。
Acta Cytol. 2002 Jul-Aug;46(4):619-29. doi: 10.1159/000326965.
3
2001 Consensus Guidelines for the management of women with cervical cytological abnormalities.2001年宫颈细胞学异常女性管理共识指南。
JAMA. 2002 Apr 24;287(16):2120-9. doi: 10.1001/jama.287.16.2120.
4
The 2001 Bethesda System: terminology for reporting results of cervical cytology.2001年贝塞斯达系统:宫颈细胞学检查结果报告术语
JAMA. 2002 Apr 24;287(16):2114-9. doi: 10.1001/jama.287.16.2114.
5
Women who participate in spontaneous screening are not at higher risk for cervical cancer than women who attend programme screening.参与自发筛查的女性患宫颈癌的风险并不高于参加项目筛查的女性。
Eur J Cancer. 2002 Apr;38(6):827-31. doi: 10.1016/s0959-8049(02)00026-6.
6
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England.英格兰宫颈癌腺癌和腺鳞癌发病率的变化情况。
Lancet. 2001 May 12;357(9267):1490-3. doi: 10.1016/S0140-6736(00)04646-8.
7
Cervical cancer screening in the Netherlands.荷兰的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2244-6. doi: 10.1016/s0959-8049(00)00317-8.
8
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.1963年至1995年芬兰有组织筛查对宫颈癌发病率和死亡率的影响:近期宫颈癌发病率上升
Int J Cancer. 1999 Sep 24;83(1):59-65. doi: 10.1002/(sici)1097-0215(19990924)83:1<59::aid-ijc12>3.0.co;2-n.
9
Non-progression of cervical intraepithelial neoplasia estimated from population-screening data.根据人群筛查数据估算的宫颈上皮内瘤变的非进展情况。
Br J Cancer. 1997;75(1):124-30. doi: 10.1038/bjc.1997.20.
10
Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit.宫颈细胞学检查报告为阴性与宫颈癌腺癌风险:无有力证据证明其益处。
Br J Cancer. 1995 Apr;71(4):894-7. doi: 10.1038/bjc.1995.172.